Powder: -20°C for 3 years | In solvent: -80°C for 1 year
WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 58.00 | |
5 mg | In stock | $ 143.00 | |
10 mg | In stock | $ 243.00 | |
25 mg | In stock | $ 397.00 | |
50 mg | In stock | $ 597.00 | |
100 mg | In stock | $ 868.00 | |
500 mg | In stock | $ 1,770.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 145.00 |
Description | WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells. |
In vitro | WJ460 dose-dependently blocks breast cancer cell invasion through Collagen I(IC50: 43.37 nM in MDA-MB-231 and 36.40 nM in BT549 cells)[1]. |
In vivo | In a spontaneous metastasis model, WJ460 inhibits angiogenesis, breast tumor growth, and spontaneous metastasis [1]. |
Molecular Weight | 460.59 |
Formula | C27H28N2O3S |
CAS No. | 1415251-36-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200 mg/mL (434.2 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
WJ460 1415251-36-3 Others WJ-460 WJ 460 inhibitor inhibit